84 results
Page 3 of 5
6-K
xdsojmktd 5onn8
11 May 21
Current report (foreign)
7:00am
POS AM
ivhkz4kewb1gt25f3
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
pg0opgzx6r ip
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
c9amkdab 73qm
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
mau8r
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
lxpmtlhvaf02 94c7fd0
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
7xw4qm03m
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
ctdq3yjo
30 Dec 20
Shelf registration (foreign)
4:17pm
F-1
x1dm5mi0
1 Jun 20
Registration statement (foreign)
12:18pm
6-K
EX-10.1
cn9fwczf
12 May 20
Current report (foreign)
12:04pm
424B5
2itaj6
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
mbr6jmoxqr 4wd8ter
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
818vd vw5phdq3kqv1
11 May 20
Prospectus supplement for primary offering
9:23am
424B5
h8py iq15
17 May 19
Prospectus supplement for primary offering
5:19pm